Fas is a member of the death receptor superfamily. The major and best known function of Fas is apoptosis. Germline and somatic mutations or deletions of FAS or FASL gene coding sequences in humans lead to autoimmune lymphoproliferative syndrome. Patients with autoimmune lymphoproliferative syndrome exhibit increased risk of both hematopoietic and non-hematopoietic cancers. Furthermore, FAS and FASL gene promoter polymorphisms are associated with decreased Fas expression level and increased risk of both hematopoietic and non-hematopoietic cancer developments in humans. Stimulation of Fas receptor also activates non-apoptotic signaling, notably NF-?B activation. However, the function of Fas-mediated NF-?B activation remains largely unknown. Our preliminary studies demonstrated that canonical NF-?B is a transcription activator of Fas and a promoter of Fas-mediated apoptosis, whereas the alternate NF-?B is a transcription repressor of Fas and suppressor of Fas-mediated apoptosis in both human colon carcinoma cells and in mouse embryonic fibroblasts. Furthermore, our preliminary studies demonstrated that blocking the canonical NF-?B activation results in a significantly increase of colon carcinoma cell metastatic potential in vivo. Based on these observations, we hypothesize that subunit composition is the molecular switch that controls the contrasting functions of the NF-?B protein complexes in Fas-mediated apoptosis and pharmacological intervention of Fas resistance is an effective approach to increase CTL immunotherapy efficacy against colon cancer metastasis. Our long-term goal is to develop a Fas-based therapy to suppress human colorectal cancer metastasis. We propose to carry out three specific aims in this project: 1) test the hypothesis that subunit composition of the NF-?B protein complex determines NF-?B functions in colon carcinoma cell apoptosis and survival; 2) test the hypothesis that NF-?B regulates Fas-mediated apoptosis pathways to mediate colon carcinoma development in vivo; and 3) test the hypothesis that apoptosis sensitization chemotherapy increases the efficacy of immunotherapy against colon carcinoma metastasis. This research project has the potential to develop an adjunct therapy to overcome Fas resistance to increase the efficacy of immunotherapy for effective suppression of spontaneous colon cancer metastasis.
This research project has the potential to develop an adjunct therapy to overcome Fas resistance to increase the efficacy of immunotherapy for effective suppression of spontaneous colon cancer metastasis.
|Liu, Kebin; Lu, Chunwan (2018) Gut microbes modulate host response to immune checkpoint inhibitor cancer immunotherapy. Transl Cancer Res 7:S608-S610|
|Lu, Chunwan; Yang, Dafeng; Sabbatini, Maria E et al. (2018) Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells. BMC Cancer 18:149|
|Xiao, Wei; Ibrahim, Mohammed L; Redd, Priscilla S et al. (2018) Loss of Fas Expression and Function is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy. Mol Cancer Res :|
|Habtetsion, Tsadik; Ding, Zhi-Chun; Pi, Wenhu et al. (2018) Alteration of Tumor Metabolism by CD4+ T Cells Leads to TNF-?-Dependent Intensification of Oxidative Stress and Tumor Cell Death. Cell Metab 28:228-242.e6|
|Ibrahim, Mohammed L; Klement, John D; Lu, Chunwan et al. (2018) Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis. Cell Rep 25:3036-3046.e6|
|Redd, Priscilla S; Ibrahim, Mohammed L; Klement, John D et al. (2017) SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells. Cancer Res 77:2834-2843|
|Lu, Chunwan; Paschall, Amy V; Shi, Huidong et al. (2017) The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion. J Natl Cancer Inst 109:|
|Liu, Feiyan; Li, Xia; Lu, Chunwan et al. (2016) Ceramide activates lysosomal cathepsin B and cathepsin D to attenuate autophagy and induces ER stress to suppress myeloid-derived suppressor cells. Oncotarget 7:83907-83925|
|Simon, Priscilla S; Bardhan, Kankana; Chen, May R et al. (2016) NF-?B functions as a molecular link between tumor cells and Th1/Tc1 T cells in the tumor microenvironment to exert radiation-mediated tumor suppression. Oncotarget 7:23395-415|
|Paschall, Amy V; Liu, Kebin (2016) An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis. J Vis Exp :|
Showing the most recent 10 out of 19 publications